Fig 3. Age-standardized rates of years of life lost (YLL) for Visceral Leishmaniasis (VL) (A) and years lived with disability (YLD) for Cutaneous and Mucocutaneous Leishmaniasis (CML) (B) per 100,000 inhabitants by age group, Brazil in 1990, 2000 and 2016.

CML mortality was assumed to be zero; YLD is low for VL (premature mortality predominates in VL). GBD Study 2016.